share_log

2连板塞力医疗(603716.SH):下属SPD及IVD业务、凝血相关生产试剂等生产研发正常开展

2-link cell therapy (603716.SH): Subsidiary SPD and IVD business, production and development of coagulation-related production reagents, etc. are progressing normally

Zhitong Finance ·  Aug 9, 2023 04:59

Zhitong Financial APP News, Seri Medical (603716.SH) announced that the company's stock trading for three consecutive trading days (August 7, August 8, August 9, 2023) the cumulative deviation of the closing price rose by more than 20%, which belongs to the situation of abnormal fluctuations in stock trading.

According to the company's self-examination, at present, all the production and operation activities of the company are normal, the market environment and industry policy have not been significantly adjusted, the production and R & D of SPD and IVD business, coagulation-related production reagents and other production and development of the company are carried out normally, and the internal production and operation order is normal. There is no major issue affecting the abnormal fluctuation of the company's stock trading price, and there is no material information that should be disclosed but not disclosed.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment